Neuropeptide Y (NPY) is a 36 amino acid peptide neurotransmitter (Tatemoto, 1982a) that is very widely distributed in both the central and peripheral nervous systems (Allen et al., 1983; Chronwall et al., 1985) . In many instances, NPY is found to be colocalized with other neurotransmitters such as norepinephrine (Chronwall et al., 1984; Ekblad et al., 1984; Ever&t et al., 1984; Jarvi et al., 1986; Wang et al., 1987) . NPY is only one member of a family of peptides that also includes peptide YY (PYY) and the pancreatic polypeptides (PP), as well as several others (Tatemoto, 1982b; Tatemoto et al., 1982) . NPY and PYY show considerable sequence homologies . Furthermore, their pharmacological effects are also similar, suggesting that they may act at the same receptors (Lundberg and Tatemoto, 1982; Edvinsson, 1985; Saria and Beubler, 1985; Morley et al., 1985; Friel et al., 1986; Serfozo et al., 1986; Zukowska-Grojec et al., 1986) . PYY is found mostly in the glicentin containing endocrine cells of the gastrointestinal mucosa and may have endocrine or paracrine functions (Bottcher et al., 1984) . Circulating PYY has been detected, and its concentration changes under various dietary conditions (Pappas et al., 1986) . In addition, however, PYY has also been detected in a unique population of neurons in the CNS (Ekman et al., 1986) . These neurons are distinct from those that contain NPY and are less widely distributed.
Not only is NPY a very widely distributed neuropeptide, but it can be shown to produce a very large number of biological effects. Following its injection into the brain, for example, NPY produces many behavioral sequelae. One of the most striking of these is an enormous stimulation of feeding (Morley et al., 1985; Stanley et al., 1986) . NPY also acts upon many peripheral systems, including a variety of smooth muscle preparations (Wahlestedt et al., 1985; Wahlestedt and Hakanson, 1986; Zukowska-Grojec et al., 1986) , the heart , and intestinal epithelia (Friel et al., 1986; Hubel and Renquist, 1986) . Interestingly, at several neuroeffector junctions, NPY appears to have both pre-and postsynaptic effects (Wahlestedt et al., 1985; Wahlestedt and Hakanson, 1986) .
Although NPY has been shown to inhibit adenylate cyclase in a number of cases, relatively little is known about the molecular basis of its action (Kassis et al., 1987; Westlind-Danielsson et al., 1987) . Some studies have identified high-affinity binding sites for NPY in the nervous system (Unden and Bartfai, 1984; Chang et al., 1986; Harfstraind et al., 1986; Martel et al., 1986) . However, nothing is known about the cellular transduction mechanisms involved in the production of NPY's neuronal effects. NPY receptors and immunoreactivity have been previously localized in the dorsal horn of the spinal cord (HBkfelt et al., 1981; Allen et al., 1983; Chronwall et al., 1985; Martel et al., 1986) . It seemed, therefore, that NPY might act as a modulator of sensory neurotransmission. In the present study, we demonstrate that sensory neurons in vitro possess high concentrations of specific NPY receptors and that activation of such receptors leads to the inhibition of voltage-sensitive Ca2+ currents and of neurotransmitter release from these cells.
Materials and Methods
Preparation of 1251-NPY and L25Z-PYY The peptides were mono-iodinated using the chloramine T method. The reaction mixture contained 0.25 M phosphate buffer, 2.8 nmol peptide, 0.5 nmol lz51 and 36 nmol chloramine T. The reaction was stopped after 1 min with 525 nmol sodium metabisulfite and transferred to a test tube containing 1 .O ml Sephadex QEA-A25 equilibrated with the following buffer: 0.08 M Trizma HCl, 0.08 M NaCl, 0.02 M HCl, and 0.02% BSA, pH 8.6.
The iodinated peptide was extracted from the Sephadex in batch rinses, which were then pooled and purified on an Altex C,, ultrasphere ion-pairing column (5 Frn particle size, 0.46 x 25 cm). The mobile phase consisted ofacetonitrile and an aqueous buffer: 0.10 M phosphoric acid, 0.02 M triethylamine, 0.05 M NaClO,, all brought to pH 3.0 with NaOH. Several mono-iodinated peaks eluted at 34% (vol/vol) ACN and 30% (vol/vol) ACN for lz51-NPY and lzsI-PYY, respectively. Peak fractions were pooled and concentrated, then desalted on a Bio-gel P-2 column (75 x 2.5 cm) equilibrated with 0.01 M Tris, 0.1% BSA, and 0.02% sodium azide. uH 7.4. The oeak fractions were nooled and concentrated, then stored-at -20°C until needed for experi-ments. For both NPY and PYY, the HPLC peak that offered maximal synthetic yield and specific binding to rat brain synaptosomes was selected as the choice peak and used in all future binding experiments.
Cell culture
Dorsal root ganglion (DRG) cells were cultured from neonatal rats as previously described (Pemey et al., 1986) .
Binding studies DRG cells. Cells were grown for 2 weeks on 35 mm plates. The culture media was aspirated and replaced with binding buffer containing 137 mM NaCl, 5.4 mM KCl, 0.44 mM KH,PO,, 1.26 mM CaCl,, 0.8 1 mM MgSO,, 20 mM HEPES, 0.3% BSA, 1 mM DTT, 0.1% bacitracin, 100 mg/liter streptomycin sulfate, 1 mg/liter aprotinin, 10 mg/liter trypsin inhibitor. and 1 UM caotouril. oH 7.4. Enough buffer was added so that the addition of cold peptide and iodinated label would bring the total volume to 1 ml. Cold peptide was added to dilute the specific activity of the label at higher concentrations. The maximal concentration of label was 100,000 cpm/ml -0.05 nM. The binding was initiated by adding iodinated label to the plates, which were then incubated with gentle shaking for 1 hr at 25°C (eauilibrium conditions). The bindinn buffer was as$rated to terminate the reaction. The plates were quickl; rinsed with 1 ml ice-cold binding buffer, aspirated, and layered with a final milliliter of buffer. The cells were scraped from the plate with a rubber policeman, transferred to a test tube, and counted for lZ51 in a gamma counter. DRG membranes. Cells were grown for 2 weeks on 35 mm plates.
The medium was aspirated and replaced with 0.5 ml of ice-cold binding buffer. The cells were scraped from the plate with a rubber policeman. The suspensions from each plate were then pooled and homogenized with a loose Teflon pestle (10-12 strokes). The resultant homogenate was stored on ice until the incubation began.
The incubation microfuge tubes were filled to a volume of 500 pl with buffer, label, and cold peptide. To initiate the reaction, 500 pl of the tissue homogenate was added to each tube, followed by shaking at 25°C for 1 hr (equilibrium conditions; Walker and Miller, 1987) . To terminate the reaction, the microfuge tube was centrifuged at 8700 x g for 15 sec. The supematant was aspirated and the top of the pellet was rinsed with 1 ml ice-cold binding buffer. The tip of the microfuge containing the pellet was cut off, dropped into a 12 x 75 mm tube, and counted for 12sI in a gamma counter.
Protein assays were performed using the Biorad method (Bradford reagent).
Binding data analysis
In all binding experiments, the total bound ligand was analyzed with a nonlinear least-squares curve-fitting program (Yamaoka et al., 198 l) , which interpreted the binding as having both saturable (specific) and nonsaturable (nonspecific) components according to adsorption isotherm models.
Microspectrojluorimetry
Measurements of [Cal+] , in single DRG cells were carried out using the dye fura-as previously described (Thayer et al., 1986) .
Substance P release
The evoked release of substance P from DRG cells was measured by radioimmunoassay as previously described (Pemey et al., 1986) . Electrophysiology DRG neurons cultured from l-d-old rat pups were voltage-clamped in the whole-cell patch-clamp configuration (Hamill et al., 1981; Marty and Neher, 1983) . Ionic conditions optimized isolation of Ca2+ currents: K+ channel blockers tetraethvlammonium (TEA+) and cesium (Cs') replaced, respectively, Na+ on the outside and K+ on the inside of the neurons, no Na+ was present, and pulses were to the Cl-equilibrium uotential. External solutions contained (in mM) 10 CaCl,, 140 TEACl. i MgCl,, and 10 glucose. Internal solutions contained (in mu) 10 EGTA; 140 CsCl, 1 MgCl,, and an ATP regenerating system ( 14 creatine phosphate, 50 U/ml creatine phosphokinase) to retard run-down of Ca*+ currents (Forscher and Oxford, 1985) . Both solutions were buffered to pH 7.4 with 10 mM HEPES.
Voltage-clamp pulses (350 msec) to 0 mV were given alternately from -40 and -80 mV at 10 set intervals. The sustained Cal+ current ("L" type) was elicited from the -40 mV holding potential and the transient Ca2+ currents ("N" and "T" types) (Nowycky et al., 1985) were additionally elicited from the -80 mV holding potential.
Inhibition of sustained and transient Ca2+ currents by various concentrations of NPY was calculated as follows. Total and sustained Ca*+ currents were plotted as a function of time and the pre-exposure time course was extrapolated as a single exponential to estimate the expected magnitudes of sustained and transient (total minus sustained) currents at the end of exposure. The percentage reduction of actual sustained and transient currents compared with these expected magnitudes was then calculated.
The patch-clamp amplifier was the Yale Mark V with 1 GQ headstage. An Indec 1 l-23 computer system was used to produce voltage-clamp pulses and record data. Calcium currents were filtered at 500 Hz and digitally sampled at 400 psec intervals. Leakage and capacitative currents were subtracted from current records by modeling the sum of the appropriate number (8 or 4) of currents produced by 10 mV hyperpolarizing pulses from holding potential and subtracting the modeled current from the raw current traces. NPY was applied by bath superfusion from a polyethylene tube positioned approximately 2 mm from the voltage-clamped neurons.
Statistics
Significance levels were determined using the 2-tailed Student's t test. (Figs. 3, 4) . Concentrations of Gpp(NH)p as low as 1 Om6 M were effective in this respect. The decrease in binding associated with the effects of Gpp(NH)p appeared to be due to the disappearance of many of the lower-affinity binding sites, so that the binding more closely resembled the whole-cell profile. It is not clear what the basis of this decline in the B,,, of the lower-affinity sites might be. One possibility is that the sites are transformed into a further form with such a low affinity that it is difficult to detect owing to limitations of the binding assay (i.e., relatively high nonspecific binding in the low-affinity concentration range).
In contrast to DRG neurons, only low levels of binding sites were observed on neurons cultured from the superior cervical ganglia of neonatal rats, on normal or differentiated PC1 2 cells, or on NG 108-15 or F-11 clonal neuronal cell lines (Table 2) .
We next investigated the functional consequences of activation of the NPY receptors located on DRG neurons. When DRG cells were depolarized by raising [K+] , from 5 to 50 mM, the release of substance P into the bathing medium was stimulated (Pemey et al., 1986) . This release could be significantly inhibited by 10m7 M NPY (Fig. 5) . It has been previously demonstrated that several other neurotransmitters can also block the evoked release of substance P from DRG cells, an effect that is associated with the inhibition of DRG Ca*+ currents (Mudge et al., 1979; Dunlap and Fischbach, 198 1) . We therefore examined the effects of NPY on DRG Ca2+ currents recorded using the whole-cell patch-clamp method. When cells were held at hyperpolarized potentials (-80 mV), steps to 0 mV evoked a large Ca2+ current that exhibited both transient and sustained components. This pattern is similar to that previously observed in chick DRG cells (Nowycky et al., 1985) . When cells were held at a relatively depolarized potential (-40 mV), steps to 0 mV evoked Ca2+ currents which exhibited little inactivation. It has been shown previously using chick DRG cells that the overall form of the DRG Ca2+ current is due to the activation of 3 separate types of voltage-sensitive Ca2+ channels (Nowycky et al., 1985) . The sustained portion ofthe current is primarily due to the activation of L channels, whereas the transient portion of the current is due to the activation of N and T channels. These latter channel types are mostly inactivated when cells are held at -40 mV.
1 Om' M NPY dramatically reduced the magnitude of the DRG Ca2+ current. Both phases of the Ca2+ current appeared to be reduced. Figure 6 illustrates the effects of NPY on the peak CaZ+ current evoked from -80 mV (transient plus sustained) and on the sustained current evoked from -40 mV. Inhibitory effects were observed at NPY concentrations as low as 1Om'o M and half-maximal effects at about 10m9 M (Fig. 7) . The Ca2+ current recovered following washout of the peptide. The effects produced by NPY were extremely reliable. Thus, the peptide inhibited the Ca*+ current in every cell tested.
The binding studies discussed above suggest that NPY receptors in DRG cells are associated with G-proteins. We therefore examined the effects of NPY following treatment of DRG cells with pertussis toxin (Fig. 8) . Following such treatment the inhibitory effects of lo-' M NPY were no longer apparent. Pertussis toxin blocked the effects of NPY on all phases of the Ca2+ current. We next examined the effects of NPY on the voltage-dependent uptake of CaZ+ into single DRG neurons using fura-based microspectrofluorimetry.
The induced rise in [Ca2+li (Fig. 9) . The inhibitory effects of NPY were no longer apparent if cultures were treated with pertussis toxin (n = 2).
Discussion
Receptors for NPY and PYY are extremely widely distributed both in the CNS and in the periphery (Chang et al., 1986; Harfstraind et al., 1986; Martel et al., 1986) . In studies to be reported elsewhere we have found that both lZ51-NPY and 1251-PYY exhibit curvilinear Scatchard plots and and appear to label 2 distinct binding sites in rat brain synaptosomes (Walker and Miller, 1987) , a similar situation to that found in DRG membranes. Furthermore, biochemical studies indicate that both ligands can interact with both binding sites. It seems, therefore, that receptors for NPY and PYY may actually be the same molecule(s), biological specificity being derived from the presence or absence of the particular peptide agonist. One area in which both NPY receptors and immunoreactivity exist in high concentrations is in the dorsal horn of the spinal cord (Hokfelt et al., 1981; Allen et al., 1983; Chronwall et al., 1985) . In the present study we have demonstrated that receptors exist on sensory neurons in vitro. It is likely, therefore, that much of the binding normally observed in the substantia gelatinosa is on the terminals of incoming sensory neurons. Such a result is consistent with the idea that one normal function of NPY might be to modulate sensory information flowing into the CNS. In support of this proposal, we have also demonstrated that NPY can reduce the depolarization-evoked release of substance P from DRG cells in vitro. Substance P is usually associated with small unmyelinated polymodal nociceptors (Aronin et al., 1983) . Thus, NPY may be involved in the normal control of pain and possibly other sensory modalities. NPY receptors appear to be one of a family of nemotransmitter receptors that can be found on sensory neurons and whose activation leads to the inhibition of substance P release. Other members of this group include CQ, GABA-B (Holz et al., 1988) and K-opioid receptors (Mudge et al., 1979) .
A question of considerable interest is how these receptors function at a molecular level and, in particular, how their activation produces inhibition of substance P release. There are several ways in which this could be achieved. For example, a change in K+ permeability (Kandel and Schwartz, 1982) or in intracellular CaZ+ buffering (Boyle et al., 1984) could be involved. However, the most direct method would be by inhibition of the voltage-dependent influx of Ca2+ into the nerve terminal. It appears that such a mechanism is widely used in both vertebrate and invertebrate neurons (Miller, 1987) . In vertebrate neurons, this phenomenon has, in fact, been most fre- Cell membranes were incubated with 20 PM lZ51-NPY for 1 hr at 25°C. Specific binding was determined in the presence of 500 nM unlabeled NPY. In the case of DRG, specific binding was determined from equilibrium curves derived from nonlinear least-sauares analvsis. All ooints are renorted as means + SE In = 31 Figure 8 . Block of NPY inhibition of DRG Ca*+ current by pretreatment with pertussis toxin. DRG neurons were exposed to pertussis toxin in culture media (350 rig/ml) for 1648 hr before recording Ca2+ currents. The data shown here were recorded after 40 hr of pertussis toxin treatment. The experimental protocol and graphic format are identical to that in quently studied in DRG cells (Dunlap and Fischbach, 1981; Werz and MacDonald, 1984; Dolphin et al., 1986) . All the different neurotransmitters discussed above that block substance P release also suppress Ca*+ currents in DRG cell bodies. If such a mechanism also occurs in the nerve terminal, then it is presumably the basis for the inhibition of substance P release. It should be noted that not all agents that block substance P release from DRG neurons do so by blocking Ca2+ currents. Thus, opioids that act on p-or &receptors, for example, appear to act by enhancing one or more DRG K+ conductances (Miller, 1984 , from 5 to 50 mM (n = 8) (Thayer et al., 1987) .
Binding studies with DRG membranes revealed the presence of 2 classes of NPY binding sites, as also found in the brain. The significance of this observation in physiological terms is difficult to assess. A reasonable argument can be made, however, that the effects of NPY on DRG Ca2+ currents are mediated by the lower-affinity sites. First, the EC,, for the effect of NPY on DRG Ca2+ currents is similar to the & of the low-affinity site or, indeed, to the Kd for the single site observed in whole-cell binding studies (approximately 1 nM). Second, in membrane preparations the properties of the low-affinity site are modulated by Gpp(NH)p, indicating that it is linked to a G-protein. The observation that pertussis toxin blocks the effects of NPY on the DRG Ca*+ current further indicates the involvement of a G-protein. With respect to the binding studies using DRG membranes, it may be considered strange that the major effect of Gpp(NH)p is on the B,,,, rather than the Kd, of the low-affinity site. However, there are several precedents for such an observation, including studies on the labeling of NPY receptors reported by other authors (Unden and Bartfai, 1984; Chang et al., 1985; Nakajima et al., 1986) . The fate of these sites is not clear. It is possible that they represent an inositol lipid-linked form of the receptor that can be shed from the membrane under the influence of a Gpp(NH)p activated enzyme such as phospholipase C (Hemperly et al., 1986) . Indeed, there are now several examples of proteins that are anchored in the membrane by being covalently linked to inositol phospholipids. More likely, however, is a shift in the state of the receptor to one of very low affinity. Indeed, other studies we have conducted using brain membranes have demonstrated that the effects of Gpp(NH)p are reversible. However, the major point to be made is that DRG cells possess large numbers of NPY binding sites. Some of these appear to be linked to G-proteins. Furthermore, the affinity of such sites is consistent with the effects of NPY on DRG Ca2+ currents.
NPY is a very potent inhibitor of DRG Ca*+ currents and of the depolarization-induced entry of Ca2+ into DRG cells as assessed by fura-2-based microspectrofluorimetry. As with other reported inhibitory modulators of DRG Cal+ currents, its effects are reversed upon treating cells with pertussis toxin (Holz et al., 1986) . This indicates the involvement of a G-protein of the G, or G, type. NPY appears to inhibit both the sustained and transient portions of the DRG Ca*+ current. By analogy with other results on chick DRG cells, it may be supposed that the sustained portion of the rat DRG current is due primarily to the activation of L channels (Nowycky et al., 1985) . This would be reasonable, as we have previously shown that the evoked release of substance P from rat DRG cells is dependent primarily on the activation of L channels. Thus, if NPY can inhibit substance P release, then presumably it should be able to inhibit L currents. However, although such a series of observations would be internally consistent, it cannot be assumed a priori that the various phases of the rat DRG Ca2+ current are due to the activation of channels with exactly the same properties as those underlying the chick DRG Ca2+ current. Indeed, it is quite clear that the inactivation kinetics of N-type currents do differ considerably in different types of neurons and possibly even in DRG cells from different species (Bean, 1987; Hirning et al., 1987) . Thus, the ultimate proofthat any particular type of Ca2+ channel is being modulated must await studies of this phenomenon at the single-channel level. Until that time, however, the above description of events seems the most reasonable and is at least consistent with other data in the literature.
The molecular mechanisms whereby NPY (or other modulators) block DRG Ca*+ currents are not known with any certainty. Some evidence suggests a role for the enzyme protein kinase C Ewald et al., 1988) . In the present case, it is noteworthy that the effects of NPY on all phases of the Ca2+ current can be reversed by pertussis toxin. If, indeed, the various phases of the current are due to the activation of different populations of Ca2+ channels, this suggests that G-proteins of the G, or G, type must be involved in the NPY-induced modulation of all these various channel types.
NPY has been shown to modulate the release of neurotransmitters from other neurons as well, including some sympathetic neurons and hippocampal pyramidal cells (Lundberg and Stjarne, 1984; Colmers et al., 1987) . It will be interesting to see if these cases also involve the modulation of neuronal Ca2+ currents.
